Firm at a glance
Avista Healthcare Partners is a platform private equity firm headquartered in New York, NY, per its website [S1].
What they buy
Based on publicly reported transactions, Avista Healthcare Partners appears to focus on healthcare sector investments [S2][S3][S4]. The firm’s recent acquisition activity includes pharmaceutical manufacturing and specialty healthcare services businesses. Observed transactions suggest an interest in established healthcare platforms with potential for operational expansion.
Portfolio
Public sources as of early 2025 identify the following investments:
**Healthcare**
* Trillium (acquired August 2024, platform) [S2]
* Cosette Pharmaceuticals (acquired July 2024) [S3]
* sanotact Group (acquired 2024) [S4]
Recent activity (last 24 months)
* **August 2024**: Acquired Trillium, a transaction that coincided with the firm rebranding as Avista Healthcare Partners [S2]
* **July 2024**: Acquired Cosette Pharmaceuticals [S3]
* **2024**: Acquired sanotact Group [S4]
How this firm fits a seller
Avista Healthcare Partners appears positioned for healthcare business owners seeking a sector-focused buyer with recent platform acquisition experience. The firm’s 2024 rebranding to emphasize healthcare suggests a strategic commitment to the sector [S2]. For sellers in pharmaceutical manufacturing, specialty healthcare services, or related verticals, the firm’s recent transaction pattern indicates active deployment. The three acquisitions completed within a twelve-month window suggest an operational tempo that may appeal to sellers seeking certainty of close.
Sources
[S1] https://avistahealthcare.com (as of 2025-01-15)
[S2] https://www.pehub.com/avista-unveils-trillium-acquisition-rebrands-as-avista-healthcare-partners/ (as of 2024-08)
[S3] https://www.lw.com/en/news/2024/07/latham-advises-on-financing-for-cosette-pharmaceuticals (as of 2024-07)
[S4] https://www.whitecase.com/news/press-release/white-case-advises-avista-healthcare-partners-and-damier-group-acquisition (as of 2024)
Frequently asked questions
Does Avista Healthcare Partners buy healthcare businesses?
Yes, per publicly available transaction records. The firm completed three healthcare acquisitions in 2024, including Trillium, Cosette Pharmaceuticals, and sanotact Group [S2][S3][S4]. The firm’s rebranding to Avista Healthcare Partners in August 2024 further signals sector specialization [S2].
What companies has Avista Healthcare Partners acquired recently?
Recent acquisitions include Trillium in August 2024 [S2], Cosette Pharmaceuticals in July 2024 [S3], and sanotact Group in 2024 [S4]. All three transactions occurred within the healthcare sector, reflecting the firm’s investment focus.
Where is Avista Healthcare Partners based and how big is the firm?
The firm is based in New York, NY [S1]. Public sources as of January 2025 do not disclose fund size, assets under management, or team headcount.
Is Avista Healthcare Partners still actively acquiring?
Based on publicly reported transactions, the firm completed three acquisitions in 2024, with the most recent in August 2024 [S2]. This recent activity suggests ongoing investment deployment, though future acquisition plans are not publicly disclosed.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.